U.S. Paper and Forestry Products Stock News

Why Paychex Stock Is Drawing Fresh Attention Paychex (PAYX) is back on investors’ radar after a recent share price move, with the stock up 8.0% over the past month and 9.6% over the past 3 months. See our latest analysis for Paychex. While the recent 8.0% 1 month share price return and 9.6% 3 month share price return point to rebuilding momentum, the stock is still down 10.7% year to date and the 1 year total shareholder return has declined 35.3%. This shows a mixed picture of short term...

Envista Holdings (NVST) has come into focus after Aristotle Small Cap Equity Fund added the dental products company as a new position, highlighting structural drivers in aging demographics and demand for restorative and aesthetic procedures. See our latest analysis for Envista Holdings. At a share price of US$23.43, Envista has had a mixed run, with the stock down 12.57% on a 1 month share price basis and 20.39% over 3 months, yet delivering a 40.13% 1 year total shareholder return as fund...

Earlier this month, Mondelez International declared a quarterly dividend of US$0.5000 per share for payment on July 14, 2026, and rolled out SOUR PATCH KIDS CHEWS and related SWEDISH FISH flavors across major U.S. retailers and online channels at price points ranging from US$1.25 to US$5.09. The launch of SOUR PATCH KIDS CHEWS, tailored to Gen Z gamers with individually wrapped, controller-friendly candy and backed by prominent Twitch and YouTube streamers, underscores Mondelez’s focus on...

Super Micro Computer (SMCI) is back in focus as multiple securities class actions and a Department of Justice indictment over alleged unlawful AI server exports to China keep legal, compliance, and reputational risks front and center for shareholders. See our latest analysis for Super Micro Computer. Recent trading reflects that tension, with a 1 day share price return of 6.34% and a 30 day share price return of 22.35%. This comes even though the 1 year total shareholder return is down 11.25%...

BridgeBio Pharma recently reported strong late-stage clinical data for acoramidis in transthyretin amyloid cardiomyopathy and encaleret in autosomal dominant hypocalcemia type 1, alongside submitting a New Drug Application to the FDA for encaleret. These advances suggest BridgeBio is moving beyond a single-product story, with encaleret potentially adding a second rare-disease franchise alongside Attruby. We’ll now examine how the positive encaleret NDA submission and ADH1 data could reshape...

Recent performance snapshot and business context Oculis Holding (NasdaqGM:OCS) has attracted fresh attention after recent trading, with the stock last closing at $29.49. Investors are weighing this price against the company’s clinical-stage pipeline and current financial profile. See our latest analysis for Oculis Holding. At $29.49, the stock has pulled back around 4.9% over the last day but still sits on a year-to-date share price return of about 47%, alongside a 1-year total shareholder...

Roblox (RBLX) has put a new US$3b share repurchase program on the table, even as it trims full year revenue guidance and faces legal questions about past user metrics and scrutiny related to platform safety. See our latest analysis for Roblox. The share repurchase announcement comes after a sharp reset in expectations, with the stock down 40.5% year to date on a share price basis and the 1 year total shareholder return declining 41.5%, while the 3 year total shareholder return remains...

Earlier in May, C.H. Robinson Worldwide received a bullish analyst upgrade from Jefferies, which highlighted the company’s early-stage technology and productivity transformation and its strong balance sheet as it prepares for potential industry consolidation in freight brokerage. Management’s focus on Lean practices, AI-driven productivity gains, and readiness to act as a consolidator amid regulatory changes is reshaping how investors view C.H. Robinson’s role in a changing logistics...

Recent share performance and business snapshot CareDx (CDNA) has drawn investor attention after recent share price moves, with the stock last closing at $21.63 and recording mixed short term returns over the past week, month and past 3 months. The company focuses on transplant related diagnostics and software, with US$412.82 million in annual revenue and a reported net income loss of US$8.192 million, placing it among mid cap US healthcare stocks. See our latest analysis for CareDx. Recent...

Aveanna Healthcare Holdings (AVAH) has put fresh earnings in focus after reporting first quarter results, with higher sales and net income than a year earlier and slightly raised full year revenue guidance. See our latest analysis for Aveanna Healthcare Holdings. At a share price of US$7.33, Aveanna has pulled back about 4% over the past week but is still up roughly 12% over 30 days. Its 1 year total shareholder return of about 38% and very large 3 year total shareholder return suggest...

Event context and quick snapshot Texas Capital Bancshares (TCBI) has drawn investor attention after recent trading, with the stock last closing at US$99.39 and showing limited movement over the past month along with a stronger total return profile over the past 3 months and year. See our latest analysis for Texas Capital Bancshares. The recent 1-year total shareholder return of 39.12% and 3-year total shareholder return of 100.67% suggest momentum has been building. This contrasts with the...

In recent months, Citizens Financial Group reported mixed first-quarter results, with revenue roughly matching forecasts, slightly higher net interest income, but tangible book value per share coming in below analyst estimates amid a softer backdrop for regional banks. At the same time, its multiyear "Reimagine the Bank" program, targeting about US$450 million in run-rate efficiency gains, underscores management’s emphasis on reshaping operations and cost structure despite near-term...

Earlier in May 2026, Dynex Capital’s board declared a US$0.17 per-share cash dividend for May, payable on June 1, 2026, to shareholders of record as of May 21, 2026. At the same time, shareholders approved doubling the company’s authorized common shares to 720 million and backed board, compensation, and governance measures, signaling support for Dynex Capital’s evolving capital structure and leadership framework. We will now examine how the doubling of authorized common shares shapes Dynex...

Earlier in May 2026, FTI Consulting appointed Andreas P. Stöcklin to lead its Transactions practice across Continental Europe and named Emanuele Grasso as Senior Managing Director and head of the Corporate Finance segment in Italy, both joining the EMEA management structure to deepen M&A and transaction support capabilities. These hires bring decades of cross-border deal experience and board advisory expertise from firms such as Kroll and PwC, highlighting FTI Consulting’s intent to build...

Sun Communities (SUI) has drawn investor attention after recent share moves, with the stock up 1.2% over the past day and 5.1% over the past week, despite declines over the past month. See our latest analysis for Sun Communities. The recent 7 day share price return of 5.1% contrasts with more muted year to date gains of 4.6% and a 1 year total shareholder return of 10.2%. This suggests near term momentum is improving from a softer medium term trend. If this move in Sun Communities has you...

Illumina, Inc. has added former Labcorp Executive Chairman and CEO David P. King to its Board of Directors, following the May 21, 2026 annual shareholder meeting and alongside equity grants to several directors as part of their compensation. King’s deep background in large-scale diagnostics businesses and clinical operations underlines Illumina’s push to embed genomics more firmly into everyday medical decision-making as it refreshes its Board. We’ll now examine how King’s board appointment,...

Recent share performance and context Oppenheimer Holdings (OPY) has seen mixed share performance recently, with the stock down about 3% over the past day and roughly 9% over the past month, yet up around 9% in the past 3 months. See our latest analysis for Oppenheimer Holdings. Despite the recent 9% decline in the 1 month share price return to US$93.86, momentum over the year still looks constructive. A 29.21% year to date share price return and a 50.07% 1 year total shareholder return...

In May 2026, MicroVision, Inc. reported first quarter 2026 results, with sales rising to US$935,000 from US$589,000 a year earlier, while net loss narrowed to US$25.29 million and basic loss per share improved to US$0.08 from US$0.12. This combination of higher sales and a smaller loss suggests incremental progress in MicroVision’s efforts to scale its lidar and perception technology business. We'll examine how this early revenue growth and reduced quarterly loss could influence...

Melco Resorts & Entertainment (MLCO) has been drawing attention after a period of weaker share performance, with the stock down over the past month and past 3 months. This has prompted closer scrutiny of its current valuation. See our latest analysis for Melco Resorts & Entertainment. At a latest share price of $5.38, Melco Resorts & Entertainment has seen its 7 day share price return fall 2.71% and its year to date share price return decline 28.36%, while the 5 year total shareholder return...

Why Post Holdings stock is on investors’ radar today Post Holdings (POST) is drawing attention after recent trading left the stock down over the past month and past 3 months, prompting investors to reassess its consumer packaged foods and foodservice footprint. At a recent close of US$97.17 and a market value of about US$4.4b, the company sits in the mid cap range for U.S. food and beverage stocks, with operations spanning cereals, pet food, refrigerated retail products, and foodservice...

Mirum Pharmaceuticals (MIRM) has just completed a zero coupon convertible note offering of $600 million due 2032, a financing move that can reshape its capital structure and influence how investors assess the stock. See our latest analysis for Mirum Pharmaceuticals. Mirum’s recent zero coupon convertible note offering comes after a mixed stretch for the stock, with the share price up 26.32% year to date but down 8.24% over 90 days. The one year total shareholder return of 124.14% and five...

Builders FirstSource previously filed a US$41.62 million shelf registration for 6,050,000 common shares tied to its ESOP and confirmed a planned leadership transition naming Mike Hiller as Chief Operating Officer-designate while appointing Coley O’Brien as Chief Human Resources Officer. This combination of an employee-focused share offering and a long-term succession plan underscores the company’s emphasis on workforce alignment and operational continuity. We’ll now examine how the COO...

Event overview and recent share performance Open Text (NasdaqGS:OTEX) has drawn fresh attention after a period in which the stock is down about 26% year to date and down about 38% over the past 3 years, prompting investors to reassess the business. See our latest analysis for Open Text. Recent price action has been choppy, with a 1 month share price return of 4.73%, a year to date share price return that is down 26.06%, and a 3 year total shareholder return that is down 37.97%, signaling that...

In May 2026, Inhibrx Biosciences reported a first-quarter net loss of US$33.44 million, narrower than a year earlier, and released positive interim Phase 2 data from its HexAgon trial of INBRX-106 plus pembrolizumab in first-line PD-L1 positive metastatic or unresectable recurrent head and neck squamous cell carcinoma. The interim data showed a higher confirmed objective response rate and the emergence of complete responses with the INBRX-106 combination, underscoring the potential...